HEMOSATE ULTRA HS1125
HEMOSATE ULTRA HS1125
Approved
DIN Number
02413892
Drug Class
Human
Market Date
Mar 30, 2020
Company
HC
chief medical supplies ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02413892
AIG Number0752576002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification
ACTIVE INGREDIENTS (7)
CALCIUM CHLORIDEActive
Strength: 6.24 G / L
Monograph: CALCIUM CHLORIDE
CITRIC ACIDActive
Strength: 6.91 G / L
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 49.5 G / L
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 2.14 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 3.35 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 1.11 G / L
Monograph: SODIUM ACETATE
SODIUM CHLORIDEActive
Strength: 263 G / L
Monograph: SODIUM CHLORIDE